GLP & METABOLIC
GLP-1S
GLP-1 receptor agonist (semaglutide-class). Studied in incretin and metabolic literature.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99.2%
purity
✓ Passed full QC panel
- Variant
- GLP-1S · 10 mg
- Lot #
- AML-2026-0505
- Labeled
- 10 mg
- Tested
- 2026-04-15
Full QC panel
- Purity (HPLC)
- 99.2%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 910463-68-2
- Molecular Formula
- C187H291N45O59
- Molecular Weight
- 4113.6 g/mol
- Sequence
- (see protein databank)
- Type
- Research peptide
- PubChem
- CID 56843331 ↗
Biological targets
Interactions
- Primary target
- GLP-1 receptor
- Pathway
- GLP-1R–cAMP; insulinotropic and appetite-axis signaling
- Mechanism
- Long-acting albumin-bound GLP-1 receptor agonist
- Research area
- Glycemic and metabolic research
Physical properties
Handling & Storage
- Appearance
- White lyophilized powder
- Solubility
- Soluble in sterile water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
MOLECULAR METABOLISM
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
2021 · PMID 33068776
Nauck MA et al.
View Source ↗JOURNAL OF MEDICINAL CHEMISTRY
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
2015 · PMID 26308095
Lau J et al.
View Source ↗THE LANCET. GASTROENTEROLOGY & HEPATOLOGY
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
2024 · PMID 39096914
Jalleh RJ et al.
View Source ↗CLINICAL PHARMACOKINETICS
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist
2018 · PMID 29915923
Hall S et al.
View Source ↗PHARMACEUTICAL RESEARCH
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
2022 · PMID 35650449
Mahapatra MK et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.